Analyst Praises AMD-Partner Absci's Practical Approach, Sees …
3 days ago · Needham has initiated with a Buy rating and a price forecast of $9.Blum writes that Absci builds its value through proprietary assets it develops in-house, such as ABS-101, 201, 301, and 501.
Absci and AMD Announce Collaboration and Strategic Investment …
Jan 8, 2025 · Absci and AMD will showcase the exceptional performance of AMD’s Instinct accelerators in addressing complex biological applications, including Absci’s proprietary IgDesign1 model, the first in vitro validated inverse folding model for antibody design.
Analyst Praises AMD-Partner Absci's Practical Approach, Sees
3 days ago · This approach allows Absci to quickly advance and monetize clinical-stage assets, aligning well with its AI/ML-driven platform. Price Action: ABSI stock is up 23% at $3.96 at the last check on ...
Absci partners with semiconductor company AMD for AI drug …
4 days ago · Absci, a data-first generative AI drug creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug discovery workloads, as well as Absci's advanced De Novo antibody design models.. In addition, AMD is making a $20 million investment in Absci. The investment will be structured as a private investment in public ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
Jan 8, 2025 · AI drug creation company Absci Corporation (NASDAQ: ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices...
Absci stock soars on AMD partnership and investment
Jan 8, 2025 · Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic collaboration and a $20 million investment from AMD (NASDAQ: AMD). The...
AMD invests $20 million in Absci to expand AI chip sales in …
Jan 8, 2025 · Investing.com -- Advanced Micro Devices (NASDAQ: AMD) is set to invest $20 million in Absci, a Washington-based drug-discovery firm, aiming to increase the use of its artificial intelligence (AI)...
Absci Announces Strategic Collaboration With AMD To Advance …
Jan 8, 2025 · (RTTNews) - Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm...
Absci Secures $20M AMD Investment, Strategic AI Drug Discovery ...
Jan 8, 2025 · Absci and AMD will showcase the exceptional performance of AMD’s Instinct accelerators in addressing complex biological applications, including Absci’s proprietary IgDesign1 model, the first in vitro validated inverse folding model for antibody design.
AMD invests $20 million in AI drug discovery firm Absci - Investing.com
Jan 8, 2025 · VANCOUVER, Wash. - Absci Corporation (NASDAQ: ABSI), a generative AI drug creation company with a market capitalization of $353 million, announced a strategic collaboration with Advanced Micro...